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Background: The c.429_452dup24 of the ARX gene is a rare genetic anomaly, leading to X-Linked Intellectual
Disability without brain malformation. While in certain cases c.429_452dup24 has been associated with specific
clinical patterns such as Partington syndrome, the consequence of this mutation has been also often classified as
“non-specific Intellectual Disability”. The present work aims at a more precise description of the clinical features
linked to the c.429_452dup24 mutation.
Methods: We clinically reviewed all affected patients identified in France over a five-year period, i.e. 27 patients
from 12 different families. Detailed cognitive, behavioural, and motor evaluation, as well as standardized videotaped
assessments of oro-lingual and gestural praxis, were performed. In a sub-group of 13 ARX patients, kinematic and
MRI studies were further accomplished to better characterize the motor impairment prevalent in the ARX patients
group. To ensure that data were specific to the ARX gene mutation and did not result from low-cognitive functioning
per se, a group of 27 age- and IQ-matched Down syndrome patients served as control.
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Results: Neuropsychological and motor assessment indicated that the c.429_452dup24 mutation constitutes a
recognizable clinical syndrome: ARX patients exhibiting Intellectual Disability, without primary motor impairment, but
with a very specific upper limb distal motor apraxia associated with a pathognomonic hand-grip. Patients affected with
the so-called Partington syndrome, which involves major hand dystonia and orolingual apraxia, exhibit the most severe
symptoms of the disorder. The particular “reach and grip” impairment which was observed in all ARX patients, but not
in Down syndrome patients, was further characterized by the kinematic data: (i) loss of preference for the index finger
when gripping an object, (ii) major impairment of fourth finger deftness, and (iii) a lack of pronation movements. This
lack of distal movement coordination exhibited by ARX patients is associated with the loss of independent digital
dexterity and is similar to the distortion of individual finger movements and posture observed in Limb Kinetic Apraxia.
Conclusion: These findings suggest that the ARX c.429_452dup24 mutation may be a developmental model for Limb
Kinetic Apraxia.
Keywords: ARX gene mutation, Kinematic study, Limb-kinetic apraxia, X-linked intellectual disability,
Partington syndromeBackground
The Aristaless Related homeoboX (ARX) gene is one of
the most important genes responsible for X-Linked
Intellectual Disability (XLID) [1-4]. Depending on the
type of mutation, ARX gene-related loss of function
leads to a pleiotropy. Nonsense mutations, for instance,
are responsible for severe brain malformations (due to
total loss of GABAergic neurons) and severe convulsive
encephalopathies such as XLAG syndrome (X-linked
Lissencephaly with Abnormal Genitalia; OMIM 300215)
[5-10]. Expansion of the first repeated PolyA sequence
of the ARX gene by insertion of 7 GCG triplets (c.333ins
(GCG)7) leads to early infantile epileptic encephalopathy
with suppression burst (Ohtahara syndrome, OMIM
308350) [11,12], or infantile epileptic-dyskinetic enceph-
alopathy without obvious brain malformation [13-16].
The most prevalent ARX mutation is a duplication of
24 bp in exon 2 (c.429_452dup24), which leads to an in-
crease from 12 to 20 alanines in the second polyalanine
tract in the ARX protein [17]. This duplication occurs in
67%-76% of all unrelated ARX mutated patients without
brain malformation [18,19], considering the potential for
ascertainment bias as the gene sequencing is not rou-
tinely available. This mutation can be associated with
either West syndrome (OMIM 308350) [2,13,20] or
Partington syndrome (OMIM 309510). The latter com-
bines ID with a very particular “dystonia” that affects
fingers and wrist movements, but has no effect on the
movements of the trunk and lower limbs [21]. Patients
with Partington syndrome also have impaired oro-lingual
praxis, leading in the most severe forms to anarthria
and permanent salivary drooling [21,22]. However, most
patients with the c.429_452dup24 mutation have been
classified as having “non specific XLID” (OMIM 300419)
because accompanying motor impairment was not obvious
[1,3,18,19,23-29]. After clinical re-evaluation, several case
reports revealed though that patients previously describedas non specific did in fact present mild “dystonic” features
as well [22,24,30,31].
To better characterize the c.429_452dup24 ARX muta-
tion consequences, we assessed all affected patients
identified in France over a five-year period (27 patients
from 12 different families) using standardized cognitive
and behavioural tests and an extensive evaluation of
motor skills, including videotaped clinical evaluation of
oro-lingual and gestural praxis. In response to the par-
ticular “reach and grasp” impairment, which seemed to
be a pathognomonic sign in this population, we per-
formed a kinematic and MRI study in a sub-group of 13
patients, in order to better characterize the phenotype.
We also included a group of 27 age- and IQ-matched
Down syndrome patients who served as controls to ensure
our data were not resulting from low-cognitive func-
tioning, but were specific to the ARX gene mutation.
Patients and methods
Patients
Recruitment procedure: Families and patients were noti-
fied of the study by the physician who ordered the gen-
etic analysis. After we informed the patients and their
parents or guardians about the aims of the study, all of
them gave written informed consent in accordance
with the Ethical Committee protocols of French Public
Hospitals (CPP DGS2007-0131, 04/18/2007) before the
study procedure started.
Patients with the c.429_452dup24 ARX mutation later
designated as ‘ARX patients’
Molecular screening: Mutation analysis on genomic
DNA was done as previously described [3]. During the
five-year inclusion period (2002–2006), 13 families were
diagnosed with the c.429_452dup24 mutation in the
ARX gene in France. Twelve families (Additional file 1:
Figure S1) agreed to be revisited. Five of these families
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studied previously. The remaining seven families had
participated in other studies [1,3,31]. Only one family
(two brothers) declined to participate in the study.
Twenty-seven males were included in the clinical study
(age range: 19 months to 56 years). All 27 patients were
examined by the same child neurologist (AC) either at
home or at the nearest hospital.
Down syndrome patients (DS)
To test the specificity of the fine motor skill impairment
and cognitive profile observed in the ARX patients, we
included a control group of 27 age- and IQ-matched
Down syndrome patients who did not have other severe
medical conditions (uncontrolled seizures or unstable
heart defect).
Healthy controls
A group of 13 age-matched healthy control subjects with
no history of neurological or psychiatric disease was re-
cruited to perform the kinematic task and undergo the
morphometric MRI.
Clinical assessment
Exhaustive clinical data were collected from the care-
giver as well as the patient’s medical records, including:
pedigree, birth parameters, early development, fine motor
skills, language, school curriculum, behavioural troubles,
antipsychotic and anticonvulsant medications, seizure
types and frequency.
Clinical examinations included dysmorphological and
neurological assessments, especially fine motor skills and
orolingual praxis.
Cognitive, adaptive, and behavioral skills were
assessed in ARX and age-matched DS patients.
Motor assessment
Videotaped oro-lingual and gestural praxis protocol
A gestural and orolingual praxis scale was specifically de-
veloped for the present study (Additional file 2: Table S1).
The scale includes fifteen items, five focused on orolingual
praxis and ten focused on gestural praxis. Given that a dif-
ference of one point regarding the mean of the oro-lingual
and gestural score was meaningful and a statistical signifi-
cance criterion of 0.05, we computed that in order to get a
power of 95% the sample size of the population included in
the study should be greater than 17. We decided to include
20% more. Twenty-one ARX and 21 age- and IQ-matched
DS patients were evaluated with this scale (mean age:
21.5 years [6.58-43.42] and 21.29 years [6.42-42.25] respect-
ively). Each item was videotaped and independently scored
on a five-point scale by two pediatric neurologists (AC and
VDP). In the case of a discrepancy between the two raters,
the videos were watched again to come to an agreement.An average “oro-lingual score” and an average “gestural
score” were determined. Given that a relatively large num-
ber of ARX patients came from two families (Family I and
II), we also computed Family-weighted scores, by applying
a weight to each ARX patient score for gestural and oro-
lingual praxis, so that each family would contribute equally
to the phenotyping. The weighted scores were thus less
sensitive to the common genetic background.
Fine motor scales
Were administered to ARX and age-matched DS patients
who participated in the kinematic study (Table 1). Family-
weighted scores were also computed for the De Renzi scale,
so that each family would contribute equally to the result.
Kinematic study
13 ARX patients and two control groups (healthy con-
trols and DS patients) participated in the kinematic and
brain MRI studies. The mean age of each group was
20.5 years [9.2-40.2], 21.30 [8.7-41.8] and 22.7 years
[10.5-42.6] respectively.
Behavioral task: The aim of this task was to reach, grasp
and lift a plastic parallelepiped block (50*30*15 mm)
from a specific starting point (Figure 1). Two variables
were analyzed: the orientation of the object and the type
of pinch. (i) The block could be set in two different ori-
entations: +56° and −56°. (ii) Participants were instructed
to successively grasp the object with three different
pinches: thumb-index finger, thumb-middle finger,
thumb-annular. For each condition, 10 movements were
recorded, with a total of 60 movements.
Movement recordings: Six infrared light-emitting diodes
(markers) were taped on the dominant hand: two on the
wrist, one on the cubital part of the thumb nail, one on
the radial part of the index finger, one on the middle
finger, and one on the annular nail. Optotrak 3020
(Northern Digital) recorded the spatial position of the
active markers at a frequency of 250Hz with a spatial reso-
lution of 0.1 mm. This task took 35 minutes to complete.
Data analysis: A second-order Butterworth dual pass
filter (cutoff frequency, 10 Hz) was used for raw data
processing. Individual movements were visualized and
analyzed using Optodisp software [40]. A window of
interest was defined as the time between the start of the
movement and the time when the subject lifted up the
block (see [41]) for detailed kinematic procedure). The
following parameters were measured (Figure 1): move-
ment duration (ms), latency (ms) and amplitude of the
acceleration peak (mm/s2), velocity peak (mm/s), Max-
imum Grip Aperture (MGA: mm). Both transport and
grasp components of movement were analyzed [42], by
studying the wrist acceleration and the velocity peak for
the transport component, and the MGA and opposition
axis for the grasp component, respectively. For each
Table 1 Neuropsychological data in ARX patients and age-matched Down syndrome patients
Function evaluated Test ARX patients DS patients Group comparison
Cognitive evaluation
Wechsler scale (n = 16/16)1
Intellectual quotient Verbal IQ (VIQ)2 49 [45 – 61] 48 [45 – 60] p = 0.33
Performance IQ (PIQ)2 52 [45 – 60] 48 [41 – 56] p = 0.28
Total IQ (TIQ) 48 [40 – 70] 45 [40 – 54] p = 0.28
Raven’s coloured progressive matrices (n = 16/16)
Non-verbal reasoning Mental age 6.9 years [4.2-11] 7.4 years [5.7-9.5] p = 0.28
Peabody Picture Vocabulary Test Revised (PPVT-R) (n = 16/16)
Receptive language Vocabulary age 8.1 years 8.2 years p = 0.96
Adaptive and behavioural assessment
Vineland adaptive behavioral scale (n = 21/21)1
Adaptive behavior Global score 43 [20–74] 53 [33–72] p = 0.02*
Communication score 32 [20–64] 39 [21–65] p = 0.07
Daily-living skills 46 [20–108] 49 [20–82] p = 0.38
Socialization skills 49 [20–72] 70 [51–101] p = 0.00002****
Nisonger child behavior rating form3 (n = 16/16)
Number of patients using the 50th percentile threshold
Behavior disorder Conduct disorder 5 0 p = 0.02*
Anxiety 7 1 p = 0.018*
Hyperactivity 5 0 p = 0.02*
Automutilation/stereotyped behavior 6 2 NS
Self-isolation/rituals 5 0 p = 0.02*
Sensitivity/susceptibility 9 1 p = 0.003***
Motor assessment
Edinburgh handedness test (n = 27/27)
Handedness Right- /Left-handed 19/7 26/1 p = 0.05*
Videotaped protocol (n = 21/21)
Praxis skills Orolingual praxis score 1.6 2.9 p = 0.00005****
Gestural praxis score 2 3.1 p = 0.0003****
De Renzi scale4 (n = 12/12)
Imitation of gestures Global score 38 [14–56] 61 [54–70] p = 0.00004****
Number of patients scoring above the
minimum normal score (>62)
0 5 p = 0.018*
Number of patients scoring in the pathological
range for apraxia (<53)
9 0 p = 0.0002***
Fingers score 13 [2–24] 29 [22–35] p = 0.00006****
Limb score 25 [22–35] 32 [28–35] p = 0.015*
Lincoln-Oseretsky motor development scale5 (n = 8/8)
Psychomotor development Global psychomotor developmental age 8.1 years [6–12] 7.4 years [6–9] p = 0.45
Manual precision 49 [25–75] 60 [38–75] p = 0.18
Global coordination 71 [29–100] 43 [14–71] p = 0.028*
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Table 1 Neuropsychological data in ARX patients and age-matched Down syndrome patients (Continued)
Alternative movements 39 [0–100] 53 [0–100] p = 0.42
Speed of wrist/fingers movement 56 [29–100] 53 [29–86] p = 0.83
Balance 50 [25–75] 9 [0–50] p = 0.003***
Manual coordination 58 [0–100] 88 [67–100] p = 0.05*
[Values] indicates the extreme values (minimum and maximum) obtained for each test.
For each scale, the normality of the data distribution was checked using the Shapiro-Wilk normality test. Then either an ANOVA or a non-parametric Mann and
Whitney test was applied to compare differences across groups. The Fisher’s exact test was used to compare the number of left-handed patients and the number
of patients with behavior disorder in ARX and DS groups.
*means <0.05, ***means <0.005 and ****means <0.001.
1Six out of 27 patients were excluded for the Vineland scale (3 younger than 5 y; 3 with severe epilepsy). Five others were excluded for the cognitive and
behavioural assessment (3 Partington with severe dystonia; 2 refusals).
2Mean VIQ and PIQ were computed for patients who had WISC-III, WAIS-III, whereas only TIQ was computed for those who had a WISC-IV scale.
3[32,33].
4[34,35].
5[36-39].
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culated for each of the six conditions.
Brain MRI
The patients were trained in a mock MRI scanner to
decrease their anxiety and minimize movements during
the scan. The acquisition was performed on a 1.5 T
Siemens scanner (CERMEP, Lyon). High resolution
(1×1×1 mm) structural imaging with a 3D T1-weighted
Fast-Spoiled Gradient Recalled (FSPGR) sequence (TR
1970, TE 3.93 ms, TI 1100 ms, FOV 256*256) was ob-
tained for each patient and age-matched healthy control.Figure 1 Kinematic task (set-up and kinematic parameters).In addition, a T2 sequence (51 axial slices, FOV 220,
voxel size: 0.9×0.9×2.5, TR 7740, TE 96) and a FLAIR
sequence were acquired. The MRI session lasted 20
minutes. None of the patients required sedation during
image acquisition. MRI images were clinically reviewed
by two paediatric neurologists (AC and VDP).
Statistical analysis
Clinical data
Statistical analysis was performed to compare the group
of ARX patients with the age- and IQ-matched DS
patients group in terms of gestural and oro-lingual
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parametric Mann and Whitney test was used. The
Fisher’s exact test was used to compare the number of
left-handed patients in ARX and DS groups. Results
were considered significant at p < 0.05.
Neuropsychological battery and behavioral scales
For each scale, the normality of the data distribution was
checked using the Shapiro-Wilk normality test. Then ei-
ther an ANOVA or a non-parametric Mann and Whitney
test was applied to compare differences across groups.
Results were considered significant at p < 0.05.
Kinematic study
Kinematic parameters were analyzed within each group
(ARX, DS, and Healthy Controls) using a repeated measure
ANOVA with two within group factors: type of pinch and
orientation. A between group analysis was also performed.
A significance level of p < 0.05 was chosen. Post-hoc ana-
lysis was performed using a Newman-Keuls test. Correla-
tions between kinematic parameters and De Renzi scale for
upper-limb apraxia were analyzed using the Pearson test.
MRI study
The vermis height was determined on the T1-weighted
sagittal medial view of each subject. The normality of
the data distribution was checked using a Shapiro-Wilk
normality test. An ANOVA was applied to compare
differences across groups.
Results
Natural history and clinical features of the whole ARX
group (27 patients)
Pregnancy and neonatal history were normal for all pa-
tients except three: one patient was born at 36 weeks of
gestation, with macrosomy and neonatal hypoglycemia due
to maternal diabetes mellitus, one had foetal bradycardia
leading to an emergency cesarean section without neonatal
neurological distress, and one had a materno-foetal infec-
tion with respiratory distress and early neonatal jaundice.
The rate of cesarean section was 33%. Birth weight, height
and head circumference were within the normal range.
Developmental trajectory: Unusual grasping was spon-
taneously reported by 82% of parents (e.g. “pinch with
three fingers”, with a more important use of the middle
finger and no use of the 4th and 5th fingers). All patients
were able to walk, often with a mild delay (mean age of
walking 20 months [min.12 – max.48]).
Delayed language was observed in all patients, but
with a large variability. The mean age at which utterance
of the first words occurred was 2.3 years [range 1–5 years],
and the mean age at which they were able to combine two
words was 3.9 years [range 2–8 years]. Among the 25 pa-
tients that were older than four years, 19 (76%) were ableto produce intelligible sentences. 6 (24%) had very severe
language impairment, either because of low cognitive level
(3 patients (12%) with severe epilepsy, one of which had
neonatal hypoglycemia and did not talk at all) or anarthria
(3 patients (12%) with Partington syndrome). Drooling oc-
curred during infancy in 56% of the patients and was still
observed at the time of examination in 21%.
Behavioral disorders were noticed during early child-
hood in 17 of 27 patients (63%), including social with-
drawal (41%), self aggressiveness (23%), hyperkinesia (17%),
and temper tantrums (25%). Most of these symptoms dis-
appeared during the second decade. Sleep problems were
infrequent (15% multiple nightly awaking during early
childhood). In teenage and adulthood, 22% were polypha-
gic, 11% had mood instability with depression, and 48%
were considered as very anxious by the caregiver. However,
only 7 out of 27 patients (26%) were on chronic psycho-
tropic medications. Most of the patients were friendly, with
a fine sense of humor. 9 out of 13 adult patients (69%) were
working (8 (61%) in a sheltered workshop and 1 (8%) in an
ordinary environment). Most of the adult patients could
commute from home to work on their own.
Epilepsy was observed in 9 patients (33%). 3 patients
(11%) presented with West syndrome (i.e. infantile spasms,
psychomotor regression, and hypsarythmia on the EEG).
Two of them, who had experienced a delay in the treatment
of their infantile spasms, were severely mentally impaired
and presented active epilepsy with multiple anticonvulsants
(Additional file 3: Table S2). The third patient with West
syndrome responded well to treatment (vigabatrin and cor-
ticosteroids) and his outcome did not differ from other
dup24 patients without epilepsy. The remaining patients
had various types of seizures (generalized tonic-clonic,
tonic, complex partial seizures, and absences). Only 3 (33%)
out of the 9 epileptic patients had sustained epileptic sei-
zures requiring multiple antiepileptic drugs; 6 (67%) were
seizure free (3 of them without treatment).
Physical and sensory features: Height, weight and head
circumference growth were in the normal ranges. There
was no obvious dysmorphia. However, striking common
physical features were noticed (Additional file 4: Figure
S2a and S2b) including high implantation of the hair or
frontal baldness (even in very young patients), long face
with thin saddle nose (with hypoplasic alae), and thin
upper lip and mild retrognathism. Valgus feet in early
childhood were common (70%). A deformation of the
rachidian static with marked hyperlordosis and dorsal ky-
phosis was observed in 81% of teenagers and adults. Fre-
quent ear infections occurred in 60%, which had lead to
surgery in 31% (ear tube, adenoidectomy, amygdalectomy).
No deafness was noticed. Refraction problems, mainly
hyperopia, were found in 16% of cases without vision loss.
Neurological examination and handedness: In 46% of
the 27 ARX patients, neurologic exams showed minor
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flexes without any spasticity or motor deficit. Orolingual
dyspraxia was mild in 18% of the patients and moderate
to severe in 82%. Patients’ speech was often fast and jerky
with a mild nasal intonation. Only 6 out of 24 patients
older than 6 years (25%) were able to write and/or read
short sentences. Ten (42%) could write their first name or
a few words. Eight (33%) could neither write nor read.
Calculation skills were generally weak, since only 7 out of
24 patients (29%) were able to perform addition and 4 pa-
tients (17%) were able to perform subtraction. Fine hand
motor skills were impaired in all patients (mild in 40% of
cases and moderate to severe in 60%). Hand grasping was
very specific (see below). 19 of the 27 ARX patients (70%)
were right-handed and 7 (26%) were strongly left-handed.
One patient, who presented severe cognitive deficit, was
ambidextrous. In comparison, only one of the 27 age-
matched DS patients was left-handed and none of the 20
healthy boys from the ARX families was left-handed. The
difference in the ratio of left- to right-handedness was sta-
tistically significant between ARX patients and healthy
controls and also between ARX and DS patients (p = 0.014
and p = 0.05 respectively, Fisher exact test).
Cognitive and behavioural profiles: comparison between
ARX and DS patients
Cognitive phenotype
No statistically significant difference was found between
the ARX and age-matched DS patients groups in measures
of IQ (Wechsler scale), visual analogical reasoning mental
age (Raven’s coloured Progressive Matrices test) and
receptive language (PPVT-R) (Table 1).
Adaptive and behavioural profiles
The global adaptive score of the Vineland questionnaire
was significantly higher in DS patients than in ARX patients
(p = 0.022), mainly regarding social skills (Table 1).
The Nisonger child behaviour scales were analyzed using
two different thresholds. When the 80th percentile threshold
was applied no significant group difference was observed.
However, no DS patients but some ARX patients scored be-
yond the pathological threshold. When the 50th percentile
threshold was applied, the number of patients exhibiting
conduct disorder, anxiety, hyperactivity, self-isolation/
rituals, and sensitivity/susceptibility was significantly
higher in the ARX group (Table 1).
Motor assessment: comparison between ARX and
DS patients
Videotaped oro-lingual and gestural praxis protocol in 21
ARX and 21 DS patients
All ARX patients older than 4 years and who could
understand the task (n = 21, Table 1), as well as 21 age-
matched DS patients, performed the praxis protocol.Global scores in the ARX population: a continuum
from mild to severe motor impairment: All of the 21
ARX patients exhibited gestural and/or oro-lingual dys-
praxia with a wide range of severity (Figure 2). No cor-
relation was found between motor skills and age or
cognitive level.
Three striking “key features” of forearm and hand move-
ments: On average, scores for gestural praxis or oro-
lingual praxis were significantly higher for DS patients
than for ARX patients (Table 1). In the DS group, all ex-
cept the two youngest patients (6:5 years and 7:7 years)
scored above 2 (Figure 2). Family-weighted scores for ges-
tural praxis and oro-lingual praxis were also significantly
higher in DS patients than in ARX patients (Mann and
Whitney, p = 0.0009 and p = 0.002 respectively).
(i) 20 out of the 21 ARX patients (95%) grasped the
pen in a very peculiar way, including the severely
affected patients with Partington syndrome for whom
even grasping a felt-tip pen was very challenging,
though they could easily kick a ball (Additional files 5
and 6). The typical “ARX pen holding” was between the
lateral sides of the middle phalanx of index and middle
fingers, and the thumb’s proximal phalanx (Figure 3).
The pulps of thumb, index and middle finger were
never involved in holding the pen. None of the DS
patients presented this atypical pen holding. The only
ARX patient who held the pen in contact with the pulp
of the index had severe expressive language impairment
with a mean oro-lingual praxis score of 1.3.
(ii) Rapid movements of pronation and supination of
the wrist and forearm (i.e. alternating positioning of
the palm and back of the hand; and moving one’s
hands as glove puppets) were impaired in 15 (71%)
out of 21 ARX patients (score < 2).
(iii) Use of the cubital part of the hand, specifically the
fifth finger, was markedly impaired (i.e. opposition
of the thumb and other fingers; grasping a bottle
with the thumb and fifth finger).
Motor scales
A statistically significant group effect between ARX and
DS patients was seen for the global score and all sub-
tests of the De Renzi upper-limb apraxia scale with
better scores for DS patients (Table 1). The ANOVA
showed a significant effect of the factor ‘group’ (ARX vs.
DS) but also an interaction between the factor ‘group’
and the within factor ‘effector’ (finger vs. limb), empha-
sizing a particular difficulty that ARX patients have with
distal movements that require independent movement
of the fingers, compared to limb movements (Figure 4,
p = 0.016). The analysis of the type of error made for
this test revealed that both groups of patients made
sequential gesture errors, but ARX patients were
Figure 2 Oro-lingual and gestural scores in 21 ARX mutated patients compared to 21 age-matched DS patients: 4 ARX patients (red
lines) showed the most severe forms, with global scores below 1 for gestural and oro-lingual praxis; 15 ARX patients (blue, green and
pink lines) had global scores between 1 and 2.5 with respect to oro-lingual and/or gestural praxis; 3 (green) had a predominantly
gestural praxis impairment (difference between the two scores of more than 1), and 2 (pink) had a predominantly oro-lingual praxis
impairment; the remaining 2 patients (dark blue) exhibited milder forms with scores just above 3.
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spatial errors (p < 0.001). Interestingly, ARX patients ex-
hibited similar impairment when performing symbolic
and non symbolic gestures, as well as when holding a
position or executing motor sequences. Family-weighted
‘Global’, ‘Fingers’ and ‘Limb’ scores for the de Renzi scale
were also significantly higher for DS patients than forFigure 3 Pen holding in ARX patients.ARX patients (Mann and Whitney, p = 0.007, p = 0.009
and p = 0.03 respectively).
The global psychomotor developmental age (Lincoln-
Oseretsky Motor Development Scale) did not signifi-
cantly differ between ARX and DS patients. However, DS
patients had significantly lower scores than did ARX
patients for ‘global coordination’ (which involves mainly
Figure 4 Significant interaction between the factor ‘group’ and the within factor ‘effector’ (fingers vs limb) on the De Renzi scale: ARX
patients were much more impaired on independent fingers movements than on global limb movements (*p < 0.05; ****p < 0.0001).
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had lower scores than did DS patients for hand coordin-
ation skills (Table 1).
Kinematic study
To further characterize ARX patients’ motor impair-
ment, a kinematic study of a grasping movement was
performed in 13 ARX patients, 13 age-matched healthy
controls and 13 age-matched DS patients. We studied
the effect of the orientation (+56° or −56°) and the
type of pinch (thumb-index, thumb-middle finger and
thumb-annular) on the movement duration and both
the transport and the grasp components.
Group effect
Movement duration
A significant group effect was found [F(2,32) = 10.6,
p < 0.001]: it took the ARX patients significantly more
time to perform the movement than it took either the
healthy age-matched controls (p < 0.001) or the DS
patients (p < 0.01). Moreover, there was no statistically
significant difference between DS and healthy age-matched
controls on movement duration, despite the Intellectual
Disability of DS patients.
Transport component
A significant group effect was found on wrist acceler-
ation and velocity peaks latencies ([F(2,32) = 9.2, p < 0.001]and [F(2,32) = 9.8, p < 0.001] respectively). Post-hoc ana-
lysis revealed that both peaks occurred significantly later
in ARX patients than in age-matched healthy controls and
DS patients (Additional file 7: Table S3). The difference
between DS patients and healthy controls was not signifi-
cant for either of the two peaks.
Grasp component
A significant group effect was found on the Maximum
Grip Aperture (MGA) latency [F(2,32) = 11.3, p < 0.001].
More precisely, post-hoc analysis showed that the
maximum distance between grasping fingers occurred
significantly later in ARX patients than age-matched
healthy controls (p < 0.001), and age-matched DS patients
(p < 0.005), while the difference between healthy controls
and DS patients was not significant.
Orientation effect
Transport component
A significant [object orientation*group] interaction
was found on acceleration peak amplitude [F(2,32) = 3.5,
p < 0.05]. In age-matched healthy controls and DS pa-
tients, a significant effect of object orientation was ob-
served on both the acceleration peak amplitude and the
velocity peak amplitude (Additional file 7: Table S3).
When the object was oriented at −56°, both the acceler-
ation peak and the velocity peak amplitudes were signifi-
cantly greater than they were for the other orientation.
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patients on the acceleration peak amplitude or on the
velocity peak amplitude (Figure 5a).
Grasp component
In age-matched healthy controls and DS patients, a sig-
nificant effect of object orientation was observed on the
MGA latency ([F(1,12) = 37, p < 0.001] and [F(1,12) = 9.9,
p < 0.01] respectively) and amplitude ([F(1,12) = 106,
p < 0.001] and [F(1,12) = 43, p < 0.001] respectively). In
fact, when the object to grasp was oriented at −56°, the
maximum distance between grasping fingers wasFigure 5 Kinematic results. a: Significant [object orientation*group] intera
significant orientation effect was observed in healthy controls and DS patie
MGA latency [F(4,64) = 7.06, p < 0.001]: ARX patients were impaired in using
between the velocity peak amplitude with the thumb-index pinch at +56°significantly smaller and occurred significantly later
than for the +56° orientation. By contrast, in ARX pa-
tients, no orientation effect was observed on the MGA
latency or amplitude.
Type of pinch effect
Movement duration
A significant [pinch*group] interaction was found on
movement duration [F(4,64) = 3.1, p = 0.02]: no pinch
effect was observed in healthy controls and DS patients,
whereas it was of borderline significance in ARX patients.ction on acceleration peak amplitude [F(2,32) = 3.45, p < 0.05]: a
nts but not in ARX patients; b: Significant [Pinch*group] interaction on
the thumb-fourth finger pinch; c: Significant positive correlation
and the De Renzi’s finger score.
Table 2 MRI analysis
Healthy controls ARX DS
Mean vermis height (mm) 47.2 47.8 37.3
Standard deviation 2.5 3.3 2.9
Group effect [F(2,36) = 56.249, p < 0.001]****
ARX/healthy controls NS
ARX/DS p < 0.001****
DS/healthy controls p < 0.001****
The normality of the data distribution was checked using a Shapiro-Wilk
normality test. An ANOVA was applied to compare differences across groups.
****means <0.001.
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movement with the thumb-annular than with the thumb-
middle finger pinch. Only 9 ARX patients out of the 13
who participated in the kinematic study were able to
complete the task with the thumb-annular pinch whereas
all the DS and Healthy age-matched controls completed it
without difficulty (Fisher exact test, p < 0.05).
Transport component
The [type of pinch*group] interaction on velocity
peak amplitude was statistically significant [F(4,64) =
2.8, p = 0.03]. Separate analysis revealed that a signifi-
cant ‘type of pinch’ effect on velocity peak amplitude
was observed for ARX patients but not for the other
two populations (Additional file 7: Table S3). Post-hoc
analysis further revealed that ARX patients had signifi-
cantly greater velocity peak amplitudes with the thumb-
middle finger pinch than with the thumb-index pinch
(p = 0.04). This preference for the middle finger over the
index was not observed in the other two groups.
Grasp component
The [pinch*group] interaction on MGA latency was
significant [F(4,64) = 7.1, p < 0.001]. In both age-matched
healthy controls and ARX patients, a significant effect of
type of pinch was observed on MGA latency, but it was
more pronounced in the ARX patients (Additional file 7:
Table S3). When patients attempted to pick up the object
with the thumb-annular pinch, the maximum distance be-
tween grasping fingers occurred significantly later in the
movement than when patients attempted to pick up the
object with the two other pinches (Figure 5b).
Correlations between De Renzi’s scores and kinematics data
in ARX patients
Correlations between the kinematic parameters and De
Renzi’s scale were analyzed in the 11ARX patients who com-
pleted both tasks. A significant, linear positive correlation
was found between the velocity peak amplitude with the
thumb-index pinch and De Renzi’s finger score (Figure 5c).
In fact, greater velocity peak amplitude of the thumb-index
pinch correlated with better De Renzi’s finger score. A sig-
nificant negative correlation was found between De Renzi’s
finger score and the following kinematic parameters: vel-
ocity peak latency (R2 = 0.61, p = 0.02), MGA latency (R2 =
0.62, p = 0.02) and movement duration (R2 = 0.53, p = 0.04),
when grasping with the thumb-annular pinch at −56°.
Brain MRI study
13 ARX patients, 13 age-matched DS patients and 13
age-matched healthy controls completed a brain MRI.
No major abnormalities were found in the ARX popula-
tion. Non-specific MRI features were observed in 6 ARX
and 5 DS patients (Additional file 8). Dilated Virchow
Robin (VR) spaces were found in all ARX patients along
the lenticulostriate arteries, and diffusively in one ofthem. It was not specific since 8 DS and 8 aged-matched
healthy controls had also enlarged VR spaces.
All but one DS patient had vermis hypoplasia (Additional
file 9: Figure S3). A significant group effect was found on
the vermis height [F(2,36) = 56.249, p < 0.001] such that DS
patients had significantly smaller vermis than the two other
groups (Table 2). No significant difference in vermis height
was found between ARX patients and healthy controls.
Discussion
The Partington syndrome: a clinically recognizable
disorder that includes all patients with a c.429_452dup24
of the ARX gene
The present study provides detailed clinical and neuro-
psychological data on 27 patients from 12 French fam-
ilies; all patients have been diagnosed with the same
c.429_452dup24 mutation in the ARX gene between
2002 and 2006. The clinical features described in this
series constitute a recognizable clinical syndrome spe-
cific to the c.429_452dup24 of ARX, which is useful for
the diagnosis of unexplained mental retardation, even in
sporadic cases. The present series is the first to describe
the cognitive profile and specific motor impairments
shared by all 27 ARX patients and demonstrates the ex-
istence of a pleiotropy. Patients with milder forms, who
were erroneously labelled “non specific ID”, exhibit atyp-
ical handling and/or articulation impairment. Patients
with the most severe form, already known as Partington
syndrome, exhibit hand dystonia and/or anarthria [21]. In
light of this spectrum of severity, we propose to consider
the term of “Partington syndrome” for all patients affected
with this mutation, to acknowledge M.W. Partington who
first described the more severely impaired patients.
We report slightly lower epilepsy prevalence in our
group (33%) compared to 45% in the Australian series
[24]. The seizures exhibited by ARX patients in our study
were of various types: tonic-clonic or complex partial
seizures, mainly sensitive to current antiepileptic drugs.
The frequency of infantile spasms (West syndrome) was
11% in our series, which is concordant with the 12.5%
rate observed in the Australian series [24]. Response to
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contrast with infantile spasms associated with the c.333ins
(GCG)7, which are usually drug resistant [14,15].
All ARX patients exhibited mild to severe orolingual
dyspraxia. A fifth of ARX patients had very severe lan-
guage impairment, either due to low cognitive level or to
speech apraxia.
With regard to motor assessment, no true pyramidal
syndrome was observed in ARX patients. This clinical
sparing of the pyramidal tracts, contrasting with the
major dystonic posture in some patients, is concordant
with the expression pattern of ARX. Indeed, ARX is
expressed in GABAergic neurons and is involved in tan-
gential migration of GABAergic neurons from the telen-
cephalon but not in radially migrating neurons, which
gives rise to pyramidal neurons in the cortical plate.
As there is a positive correlation between the handed-
ness of a child and the handedness of its biological par-
ents [43], we chose to compare the ARX patients to the
healthy controls (males) from their families. We reported
a higher frequency of strong left-handedness in ARX
patients compared to healthy controls and DS patients. In
the literature, the great majority (90%) of the human
population is right-handed [44]. This percentage contrasts
with the one found in ARX patients (70%). The ontogenesis
of handedness is usually thought as a multifactorial model
[45]. ARX being a transcription factor expressed early in
brain during the development, it could be interesting to
test if ARX can regulate some of the 27 genes identi-
fied as asymmetrically expressed in the left and right
hemisphere of 12-week-old human fetal brains [46].
The particular “reach and grip” impairment, which was
observed in all ARX patients, was further characterized by
the videotaped scale and kinematic data. Comparison of
ARX patients and age-matched DS patients was useful in
distinguishing between motor problems due to intellectual
deficit and distortions linked to a specific ARX profile. For
instance, both ARX and DS patients had lower acceler-
ation and velocity peak amplitudes compared to age-
matched healthy controls. This finding was most likely
related to the Intellectual Disability of ARX and DS pa-
tients. However, all other parameters that were im-
paired in ARX patients were spared in DS patients.
Three key features affecting digits, hands, wrist and
forearm movements are shared by ARX patients:
(i) Loss of preference of the index finger for grasping.
Ninety-five percent of the ARX patients in our series
held a pen in a very specific way, between the lateral
sides of the index and middle fingers, with the pen lean-
ing upon the thumb’s proximal phalanx, without directly
contacting the pulp of the fingers. Turner described this
way of holding the pen as an “odd posture” of the handin two unrelated families [30]. When they were pre-
sented with our kinematic task, ARX patients had sig-
nificantly greater velocity peak amplitudes with the
thumb-middle finger pinch than with the thumb-index
finger pinch. This preference for the middle finger
instead of the index was not observed in age-matched
healthy controls and DS patients.
By studying the precision grasps of small beads of dif-
ferent sizes in 48 healthy children and 90 adults, Wong
and Whishaw [47] described a high degree of variability
in digit contact strategies, purchase patterns, and pos-
ture of the non grasping digits, depending on bead and
hand size. However, a lateral grip missing any pulp con-
tact of either the index or the thumb, such as observed
in our ARX population, was never noticed. Similarly,
among the various purchase strategies described, the use
of the thumb and the middle finger, skipping the index,
was very uncommon and considered improper. Con-
versely, the thumb-index pincer was used in more than
90% when grasping smaller beads, which were much
more difficult to purchase [47].
(ii) Major impairment of fourth and fifth fingers
deftness
It is interesting to note that the unusual grip posture
spontaneously observed during the infancy of ARX
patients by their parents (“pinch with three fingers” with
a more important use of the major and no use of the 4th
and 5th finger), persisted during adulthood, in an even
more discrete way, as demonstrated in the kinematic study.
In age-matched healthy controls and DS patients, the diffi-
culty induced by the use of the thumb- fourth finger pinch,
which is unusual, did not have any impact on the move-
ment duration. By contrast, ARX patients took significantly
more time to perform the movement with the thumb-
fourth finger pinch than with the thumb-middle finger.
Furthermore, the MGA latency for the thumb-fourth finger
pinch was much more pronounced in ARX patients than
in controls. In addition, only nine out of the thirteen ARX
patients were able to complete the task with the thumb-
fourth finger pinch though they completed the task utiliz-
ing the two other types of pinch without much trouble.
(iii) Lack of pronation/supination movements of the
wrist and forearm.
In age-matched healthy controls and DS patients, but
not in ARX patients, we found an orientation effect on
both transport and grasp components. The +56° condi-
tion has been shown to be the easiest orientation for
grasping an object [48]. At −56°, the movement duration
was longer, the MGA occurred later and was smaller.
This data suggests that the −56° condition was a more
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motor control [49-51]. Acceleration and velocity peak
amplitudes were higher at −56°. It is likely that the
increase of acceleration and velocity peak amplitudes
at −56° in healthy controls and DS patients compared to
ARX patients is related to the pronation movement used
by the DS and healthy controls to grasp the object
at −56°. ARX patients did not show such an effect on
either transport parameters or grasp parameters. In fact,
ARX patients elevated their elbows rather than pronating
their wrist in order to grasp the object at −56°. This
observation is consistent with the finding that ARX
patients exhibited impaired performances of rapid move-
ments of pronation and supination of the wrist.
The term “focal dystonia” has often been used to describe
the very specific hand grip of patients affected with
Partington syndrome. However, the general definition of
dystonia requires simultaneous co-contraction of agonist
and antagonist muscles, leading to sustained hypertonia.
In ARX patients, by contrast, weakness of muscles has
been seen (but not stiffness) with a spontaneous position
of the wrist at rest in a limp flexed position, both in the
present and in past studies [24]. This awkward position at
rest, which could have been mistaken for unusual hand
mannerisms, does not fit with the definition of focal
dystonia, which occurs during voluntary movement.
Partington syndrome, a developmental model of Limb
Kinetic Apraxia (LKA)
The term apraxia indicates an inability to perform pur-
poseful movements in the absence of sensory-motor def-
icits or impaired understanding of what is required [52].
Classically, three types of limb apraxia have been identi-
fied: the ideational apraxia (patients do not know what
to do), the ideomotor apraxia (patients know what to do
but not how to do it), and Limb-Kinetic Apraxia (LKA)
[52-54]. LKA was defined one century ago by Kleist, as
“a loss of hand and finger dexterity resulting from inability
to connect or isolate individual finger movements” [55].
The De Renzi upper-limb apraxia scale has been devel-
oped to distinguish LKA from ideomotor apraxia [35]. In
our study, DS and ARX patients both exhibited a signifi-
cant rate of ‘sequence’ errors, likely related to a common
disability in motor programming resulting from their In-
tellectual Disability. Specifically, DS patients had signifi-
cantly higher scores on the De Renzi scale than the ARX
patients, and no DS patient scored below the pathological
range for apraxia. Conversely, none of the ARX patients
reached the minimum normal score, and 75% scored in
the pathological range for apraxia. Furthermore, only ARX
patients exhibited a high rate of awkwardness and spatial
errors, similar to patients affected with LKA associated
with CorticoBasal Degeneration (CBD) [35]. Interestingly,
ARX patients fulfil two major clinical criteria for LKAdiagnosis [54]: (i) impaired, coarse execution of simple
movements of the hand, more evident distally than prox-
imally and most notable for incoordination between fin-
gers. It is striking to see how ARX patients were much
more impaired in assessment of distal movement, which
demanded independent finger movements, compared with
more global movement, which involved the whole super-
ior limb; (ii) impairment of all movements, i.e. symbolic/
non symbolic, transitive/intransitive. ARX patients were
similarly impaired in their performance of symbolic or
non-symbolic gestures, and in holding a position or carry-
ing out motor sequences. The core deficit in LKA is a
distortion of individual finger movements and posture,
similar to the peculiar ARX patients’ grasping behaviour.
In addition, ARX patients exhibit buccofacial apraxia or at
least tongue and lips movement impairment, as observed
in patients with corticobasal degeneration [56,57].
The so called “LKA” observed in ARX subjects is a
unique form of LKA for several reasons: ARX-related
apraxia is (i) a “pure” LKA, without bradykinesia, rigidity
and dystonia, three movement impairments commonly
seen in corticobasal degeneration [54], allowing a better
analysis of LKA pathophysiology; (ii) a bilateral LKA, by
contrast with LKA in CBD which is mainly unilateral
[54]; (iii) a developmental impairment observed as soon
as in infancy, without obvious worsening with aging on
retrospective data.
The pathophysiology of LKA suggests an impaired
cortical inhibition for selection and control of hand
muscular activity [53] and may be the result of loss of
cortical inhibitory interneurons either in the frontal lobe
or in the basal ganglia in CBD [53]. In Parkinson disease,
the LKA seems also to be related to cortico-basal ganglia
network dysfunction [58]. Since ARX is mainly expressed
in inhibitory GABAergic interneurons of the developing
cortex and striatum [59], a similar mechanism might be
suggested in ARX mutated patients.
Visual inspection of the brain MRI of ARX patients
did not reveal major basal ganglia abnormalities. The
mild cystic images observed in most ARX patients located
just beneath the putamen have the signal characteristics of
CSF on MRI (Hyper T2, Hypo T1 and FLAIR images) and
represent most probably a simple enlargement of the
Virshow-Robin spaces along the lenticulo-striatal vessels.
Nevertheless, it is questionable that obvious prominent
cysts were already described in the posterior putamen of
patients carrying the c.333ins(GCG)7 in the first polyala-
nine tract of the ARX gene [14]. Moreover, neuropatho-
logic studies of the brain in newborn males affected with
the XLAG syndrome (lack of ARX protein) show poorly
delineated and atrophic basal ganglia and multiple small
cavitations [5]. Besides, ARX has a major role in regulating
basal ganglia differentiation in mice [60,61]. Interestingly,
there was no difference in vermis height between ARX
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smaller vermis compared to both groups. The normal
cerebellar structure is concordant with the lack of expres-
sion of the ARX gene in the cerebellum [1] and good gross
motor skills of ARX patients.
Conclusion
The c.429_452dup24 mutation of the ARX gene consti-
tutes a recognizable clinical syndrome: ARX patients
exhibiting Intellectual Deficiency with no primary motor
impairment, but with a very specific upper limb distal
motor apraxia associated with a pathognomonic hand-
grip. A continuum of severity level is observed ranging
from the milder form, exhibiting atypical handling and/
or articulation impairment, to the most severe form, with
hand dystonia and/or anarthria. The ARX c.429_452dup24
mutation may be a developmental model for Limb
Kinetic Apraxia.
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